New Drug Development : A Regulatory Overview

Cover of New Drug Development : A Regulatory Overview by Mark P. Mathieu
Year: 1997
Language: en
Edition: 6th
Pages: 358
ISBN-13: 9781882615421
Dimensions:
Height: 9.5 Inches
Length: 1 Inches
Weight: 2.38 Pounds
Width: 6.75 Inches
Dewey Decimal: 363.19/46/0973
Editorial overview Touché

New Drug Development: A Regulatory Overview by Mark P. Mathieu is a comprehensive resource published by Parexel International Corporation in 1997. This sixth edition spans 358 pages and is presented in English, offering insights into the regulatory landscape surrounding drug development in the United States.

Readers will find a detailed examination of the processes and laws governing the pharmaceutical industry, particularly focusing on the role of the United States Food and Drug Administration. The book addresses critical aspects of drug law and legislation, providing a thorough understanding of the regulatory framework that shapes drug development practices. This edition serves as a valuable reference for those interested in the intersection of pharmaceuticals and regulatory compliance.


Official synopsis Publisher

Book by Mathieu, Mark P., Evans, Anne G.

FAQ
What is “New Drug Development : A Regulatory Overview” about?
This page includes the available description and bibliographic details for “New Drug Development : A Regulatory Overview” by Mark P. Mathieu. Synopsis preview: Book by Mathieu, Mark P., Evans, Anne G.
Who is the author of “New Drug Development : A Regulatory Overview”?
“New Drug Development : A Regulatory Overview” is credited to Mark P. Mathieu.
When was “New Drug Development : A Regulatory Overview” published?
Publisher: Parexel Intl Corp. Year: 1997.
What is the ISBN for “New Drug Development : A Regulatory Overview”?
ISBN-13: 9781882615421.
What are the book details (language, pages, edition)?
Language: en. Pages: 358. Edition: 6th.

Related Books by Topic